|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2006-8-2
|
|
pubmed:abstractText |
Hürthle cell carcinoma is an uncommon and occasionally aggressive differentiated thyroid cancer associated with increased mortality compared with other differentiated thyroid malignancies. Because it generally has lower iodine avidity, 18F-FDG PET has been suggested as a more accurate imaging modality. However, there is limited information with regard to the true diagnostic accuracy and prognostic value of 18F-FDG PET in this disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1260-6
|
|
pubmed:meshHeading |
pubmed-meshheading:16883003-Adenoma, Oxyphilic,
pubmed-meshheading:16883003-Adult,
pubmed-meshheading:16883003-Aged,
pubmed-meshheading:16883003-Aged, 80 and over,
pubmed-meshheading:16883003-Female,
pubmed-meshheading:16883003-Fluorodeoxyglucose F18,
pubmed-meshheading:16883003-Humans,
pubmed-meshheading:16883003-Male,
pubmed-meshheading:16883003-Middle Aged,
pubmed-meshheading:16883003-Positron-Emission Tomography,
pubmed-meshheading:16883003-Predictive Value of Tests,
pubmed-meshheading:16883003-Prognosis,
pubmed-meshheading:16883003-Thyroglobulin,
pubmed-meshheading:16883003-Thyroid Neoplasms,
pubmed-meshheading:16883003-Tomography, X-Ray Computed
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
|
|
pubmed:affiliation |
Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. prymada@upmc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
